Profil
Todd Kinsella is currently the Head-Biology at Vividion Therapeutics, Inc. He previously worked as Vice President-Research at Rigel Pharmaceuticals, Inc. Dr. Kinsella holds a doctorate degree from Stanford University and an undergraduate degree from the University of Arizona.
Postes actifs de Todd Kinsella
| Sociétés | Poste | Début |
|---|---|---|
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Corporate Officer/Principal | 01/12/2017 |
Anciens postes connus de Todd Kinsella
| Sociétés | Poste | Fin |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Todd Kinsella
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
















